VI Autologous Bone Marrow Transplantation.pdf - Blog Science ...
VI Autologous Bone Marrow Transplantation.pdf - Blog Science ...
VI Autologous Bone Marrow Transplantation.pdf - Blog Science ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
1992;10:175-7.<br />
3. McMillan A, Goldstone A. What is the value of autologous bone marrow transplantation<br />
in the treatment of relapsed or resistant Hodgkin's disease? Leuk Res<br />
1991;15:237-43.<br />
4. Phillips GL, Reece DE, Connors JM. <strong>Bone</strong> marrow transplantation in Hodgkin's<br />
disease. <strong>Bone</strong> <strong>Marrow</strong> Transplant 1992;10(Suppl l):64-6.<br />
5. Desch CE, Lasala MR, Smith TJ, et al. The optimal timing of autologous bone<br />
marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse.<br />
J Clin Oncol 1992;10:200-9.<br />
6. Buzaid AC, Lippman SM, Miller TP. Salvage therapy of advanced Hodgkin's<br />
disease: Critical appraisal of curative potential. Am J Med 1987:83:523-32.<br />
7. Longo DL, Duffey PL, Young RC et al. Conventional-dose salvage combination<br />
chemotherapy in patients relapsing with Hodgkin's disease after combination<br />
chemotherapy: The low probability for cure. J Clin Oncol 1992;10:210-8.<br />
8. Reece DE, Barnett MJ, Connors JM et al. Intensive chemotherapy with cyclophosphamide,<br />
carmustine, and etoposide followed by autologous bone marrow transplantation<br />
for relapsed Hodgkin's disease. J Clin Oncol 1991;9:1871-9.<br />
9. Harden E, Bolwell B, Fay J et al. Treatment of progressive Hodgkin's disease (HD)<br />
with cyclophosphamide (C), BCNU (B) and continuous infusion etoposide (V): CBVi<br />
and autologous marrow transplantation (AMT) [abstract]. Proc Am Soc Clin Oncol<br />
1990;9:271.<br />
10. Wheeler C, Antin JH, Churchill WH et al. Cyclophosphamide, carmustine, and<br />
etoposide with autologous bone marrow transplantation in refractory Hodgkin's<br />
disease and non-Hodgkin's lymphoma: A dose-finding study. J Clin Oncol<br />
1990;8:648-56.<br />
11. Kessinger A, Armitage JO, Smith DM, et al. High-dose therapy and autologous<br />
peripheral blood stem cell transplantation for patients with lymphoma. Blood<br />
1989;74:1260-5.<br />
12. Klingemann H-G, Eaves AC, Onetto N et al. Randomized trial of GM-CSF (2 hour<br />
versus 24 hour infusion) after autologous bone marrow transplantation (AuBMT) for<br />
Hodgkin's disease [abstract]. Exp Hematol 1991;19:558.<br />
13. Lohri A, Barnett M, Fairey RN et al. Outcome of treatment of first relapse of<br />
Hodgkin's disease after primary chemotherapy: Identification of risk factors from<br />
the British Columbia experience 1970 to 1988. Blood 1991;77:2292-8.<br />
14. Gianni AM, Siena S, Bregni M et al. Prolonged disease-free survival after high-dose<br />
sequential chemo-radiotherapy and haemopoietic autologous transplantation in<br />
poor prognosis Hodgkin's disease. Ann Oncol 1991;2:645-53.<br />
15. Jones RJ, Vogelsang GB, Hess AD et al. Induction of graft-versus-host disease after<br />
autologous bone marrow transplantation. Lancet 1989;1:754-7.<br />
16. Carella AM, Carlier B, Congiu A et al. <strong>Autologous</strong> bone marrow transplantation as<br />
adjuvant treatment for high-risk Hodgkin's disease in first complete remission after<br />
MOPP/ABVD protocol. <strong>Bone</strong> <strong>Marrow</strong> Transplant 1991:8:99-103.<br />
SIXTH INTERNATIONAL SYMPOSIUM ON AUTOLOGOUS BONE MARROW TRANSPLANTATION 89